TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Self-rated technical ability in blood pressure measurement
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Thirty-day mortality
Endpoint domain: Mortality/survival
Primary endpoint: MACE at 30 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Delivery time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Success rate of abortion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Incidence of CHF
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Severity of mucosal inflammation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Cure and markedly improved rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Primary clinical end point
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Need for a second coronary angioplasty
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: areas of secondary hyperalgesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: relative safety and efficacy of tiotropium formulations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Agreement between plasma gentamicin concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in port patency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: healthy survivors
Endpoint domain: Mortality/survival
Primary endpoint: abnormal prenatal cerebral findings
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: systolic pulmonary venous flow velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: diastolic left ventricular function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: maximal ST-segment depression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Composite of all-cause death and unplanned hospitalization for heart failure
Endpoint domain: Mortality/survival
Primary endpoint: Change in depression
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: T-cell production of IFN-gamma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: early recurrent bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Burden of anemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Improvement in skin texture
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Reduction in postacne pigmentation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Passive and active extension ROM
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: 6 Minute Walk Distance (6 MWD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Event-free survival (FFS)
Endpoint domain: Mortality/survival
Primary endpoint: Proportion of infants developing cellular and/or humoral immunity to measles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Mean stimulation index (SI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: clinical and angiographic restenosis rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Patient assessment rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fracture rate
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of secondary interventions
Endpoint domain: Resource use
Primary endpoint: Proportion of vaginal deliveries
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Average duration of labour
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Proportion of positive response after 48h
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: forced vital capacity decline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: forced expiratory volume in 1 second decline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Huang scores decline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Oxygen saturations post-surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FEV1 AUEC(0‐12 weeks)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Proportion of patients reaching LDL-C <70 mg/ml
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Improvement in nutritional status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Improved respiratory conditions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Median survival for patients with ERCC1 mRNA levels
Endpoint domain: Mortality/survival
Primary endpoint: Confidence of feedback mechanism
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Comfort of mouthpiece
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Swollen joint count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Satisfaction with medication
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Disease-specific survival
Endpoint domain: Mortality/survival
Primary endpoint: Biochemical failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Immunogenicity of the split‐virion pH1N1 vaccine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Emergence time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Airway irritation incidence
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of patients remaining on antidepressant medication
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: participant-rated goal attainment
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Delayed postoperative bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: Postpolypectomy coagulation syndrome
Endpoint domain: Adverse events/effects
Primary endpoint: urinary leukocyturia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Urinary outcomes
Primary endpoint: per-procedure costs
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Pao2/Fio2 (P/F) ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Time to extubation
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: IgG antibody levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: persistent RV dysfunction at 48h
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: persistent RV dysfunction at 7 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: IGA mod 2011 0/1 response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient-assessed acceptability of the autoinjector
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: cough score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Walking at moderate-intensity for >= 10 minutes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: satisfaction with the taped consultation
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: recall of diagnostic information
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Acute kidney injury
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Performance measures during the BEAST
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fatigue effect associated with the BEAST
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: VTE prevention
Endpoint domain: Physiological/clinical
Primary endpoint: urine leaks per week
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: urine loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IIQ score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Circulating IGF‐I levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: IGFBP‐3 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: IGF‐I/IGFBP‐3 molar ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Symptomatology maintenance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Meaningful changes
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Use of lipid-lowering drugs
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Use of anti-hypertensive drugs
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Use of anti-thrombotics
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Prediction accuracy of IVS thickness clusters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cumulative success probability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cumulative percentage of functioning bleb
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: postoperative intraocular pressure (IOP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: plasma α‐tocopherol status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: diet quality
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Prevalence of tobacco use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion eating five portions of fruit and vegetables daily
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum concentration of methylphenidate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the plasma drug concentration-time curve
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: lesion resolution
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: seizure recurrence
Endpoint domain: Adverse events/effects
Primary endpoint: Healing of digital lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevention of new digital ulcers (DUs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in standardized BMI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: stereoacuity improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postconcussion symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Probability of biochemical progression at 36 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adherence to condoms and/or PrEP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: composite spasticity score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: remission rates at 6-month follow-up
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: transplant-related mortality
Endpoint domain: Mortality/survival
Primary endpoint: mortality predictions
Endpoint domain: Mortality/survival
Primary endpoint: Mean cotinine levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: global rating score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: percentage of key score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: younger children's risk of injury
Endpoint domain: Adverse events/effects
Primary endpoint: Uterine tachysystole or hypertonus
Endpoint domain: Adverse events/effects
Primary endpoint: Inhibition of AChE and BuChE
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CSF AChE protein levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: intact margin ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: open margin ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of margin deterioration
Endpoint domain: Adverse events/effects
Primary endpoint: Diagnostic performance for CAD detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Increase in serum bicarbonate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: residual rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Agreement between TDS and gold standard for evaluating TCT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reproducibility of the TDS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intra-rater reliability of TDS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in dyspepsia symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: TCC in nasal lavage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: loss of body fat
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: increase in cardiovascular fitness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: improvement in fasting insulin level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Cotinine in urine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HbA1c reduction (%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of confirmed hypoglycaemia (episodes/patient-year)
Endpoint domain: Adverse events/effects
Primary endpoint: Bodyweight change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PASI improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DLQI reduction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Frequency of hypolactasia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Symptoms compatible with lactose intolerance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Cerebrospinal fluid drainage volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Disease free survival (DFS)
Endpoint domain: Mortality/survival
Primary endpoint: degree of early sedation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 90-minute alertness scale score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pain on injection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: complete success rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: occlusion rates at 6 and 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: side effects (haematoma, phlebitis, thrombophlebitis)
Endpoint domain: Adverse events/effects
Primary endpoint: sleep continuity
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: average annual mortality
Endpoint domain: Mortality/survival
Primary endpoint: primary success
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percent weight loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: clinically significant weight loss (i.e., 5 %)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 1-year cumulative re-bleeding rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improvements in scores for depression
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: reductions in surrogate markers of suicidal behaviour
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: target-vessel failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in ambulatory systolic blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in ambulatory diastolic blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: mean protein requirement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Bowel symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Urinary symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Diminished physical functioning
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Diminished role functioning
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: AUC((0-96 h))
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of gastric insufflation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean peak airway pressure during ventilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean IQ scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: behaviour problems
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Resectability
Endpoint domain: Mortality/survival
Primary endpoint: BPRS change scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: frequency of favorable ratings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of new-onset diabetes mellitus
Endpoint domain: Adverse events/effects
Primary endpoint: psychological quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: distance walked on the Six-Minute Walk test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: serum TAG concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: CCK concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: gallbladder ejection fraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Decrease in agitated behaviors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ease-of-care ratings
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Reduction in nursing staff burden
Endpoint domain: Life impact
Endpoint subdomain: Societal/carer burden
Primary endpoint: Incidence of propofol-induced pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median pain score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of death from any cause
Endpoint domain: Mortality/survival
Primary endpoint: Risk of readmission for worsening of heart failure
Endpoint domain: Mortality/survival
Primary endpoint: PCSK9 concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: LDL-C reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood glucose self-assessment usage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Skills and confidence for self-management
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Amplitude of parietal N20 and frontal N30 SEP components
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: 3D shape approximation of tumors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of pregnancy-induced hypertension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Incidence of hypertension before 37 weeks of pregnancy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Atazanavir AUC0-last
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean total testosterone level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: calculated free testosterone
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: bioavailable testosterone
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Postoperative memory performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes